Search research articles
Contact Us
Filters
Showing results (651-660 of 665) with videos related to
Page
of 67
Sort By:
Plos Biology
|
September 4, 2020
Porphyromonas gingivalis promotes progression of esophageal squamous cell cancer via TGFβ-dependent Smad/YAP/TAZ signaling
Yi-Jun Qi, Ye-Lin Jiao, Pan Chen, et al.
Frontiers in Pharmacology
|
October 31, 2022
Efficacy and safety of remimazolam besylate in bronchoscopy for adults: A multicenter, randomized, double-blind, positive-controlled clinical study
Ying-Yong Zhou, Shu-Ting Yang, Kai-Ming Duan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 12, 2020
Hypofractionated Versus Conventional Fractionated Radiotherapy After Breast-Conserving Surgery in the Modern Treatment Era: A Multicenter, Randomized Controlled Trial From China
Shu-Lian Wang, Hui Fang, Chen Hu, et al.
JAMA Network Open
|
November 30, 2021
Postoperative Chemoradiotherapy With Capecitabine and Oxaliplatin vs Capecitabine for Stage II to III Rectal Cancer: A Randomized Clinical Trial
Ning Li, Yuan Zhu, Lu-Ying Liu, et al.
The Lancet. Oncology
|
April 19, 2014
Conventional stents versus stents loaded with (125)iodine seeds for the treatment of unresectable oesophageal cancer: a multicentre, randomised phase 3 trial
Hai-Dong Zhu, Jin-He Guo, Ai-Wu Mao, et al.
Chinese Journal of Integrative Medicine
|
June 13, 2025
Shexiang Tongxin Dropping Pill Improves Stable Angina Patients with Phlegm-Heat and Blood-Stasis Syndrome: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Ying-Qiang Zhao, Yong-Fa Xing, Ke-Yong Zou, et al.
Cancer Reports (Hoboken, N.J.)
|
March 15, 2023
Clinical characteristics, treatment, and survival of 30 patients with gastrointestinal natural killer/T-cell lymphoma
Jia-Xin Liu, Xin Liu, Yong Yang, et al.
Leukemia
|
September 18, 2020
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study
Yong Yang, Ying Wang, Xin Liu, et al.
American Journal of Hematology
|
May 26, 2020
Risk-based, response-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group study
Shu-Nan Qi, Yong Yang, Yu-Jing Zhang, et al.
Blood Advances
|
July 14, 2020
First-line non-anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG
Shu-Nan Qi, Yong Yang, Yu-Qin Song, et al.
Page
of 67
Search research articles
Search
Showing results (651-660 of 665) with videos related to
Sort By:
Page
of 67
Plos Biology
|
September 4, 2020
Porphyromonas gingivalis promotes progression of esophageal squamous cell cancer via TGFβ-dependent Smad/YAP/TAZ signaling
Yi-Jun Qi, Ye-Lin Jiao, Pan Chen, et al.
Frontiers in Pharmacology
|
October 31, 2022
Efficacy and safety of remimazolam besylate in bronchoscopy for adults: A multicenter, randomized, double-blind, positive-controlled clinical study
Ying-Yong Zhou, Shu-Ting Yang, Kai-Ming Duan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 12, 2020
Hypofractionated Versus Conventional Fractionated Radiotherapy After Breast-Conserving Surgery in the Modern Treatment Era: A Multicenter, Randomized Controlled Trial From China
Shu-Lian Wang, Hui Fang, Chen Hu, et al.
JAMA Network Open
|
November 30, 2021
Postoperative Chemoradiotherapy With Capecitabine and Oxaliplatin vs Capecitabine for Stage II to III Rectal Cancer: A Randomized Clinical Trial
Ning Li, Yuan Zhu, Lu-Ying Liu, et al.
The Lancet. Oncology
|
April 19, 2014
Conventional stents versus stents loaded with (125)iodine seeds for the treatment of unresectable oesophageal cancer: a multicentre, randomised phase 3 trial
Hai-Dong Zhu, Jin-He Guo, Ai-Wu Mao, et al.
Chinese Journal of Integrative Medicine
|
June 13, 2025
Shexiang Tongxin Dropping Pill Improves Stable Angina Patients with Phlegm-Heat and Blood-Stasis Syndrome: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Ying-Qiang Zhao, Yong-Fa Xing, Ke-Yong Zou, et al.
Cancer Reports (Hoboken, N.J.)
|
March 15, 2023
Clinical characteristics, treatment, and survival of 30 patients with gastrointestinal natural killer/T-cell lymphoma
Jia-Xin Liu, Xin Liu, Yong Yang, et al.
Leukemia
|
September 18, 2020
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study
Yong Yang, Ying Wang, Xin Liu, et al.
American Journal of Hematology
|
May 26, 2020
Risk-based, response-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group study
Shu-Nan Qi, Yong Yang, Yu-Jing Zhang, et al.
Blood Advances
|
July 14, 2020
First-line non-anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG
Shu-Nan Qi, Yong Yang, Yu-Qin Song, et al.
Page
of 67